top of page
The University of Kansas Medical Center's mission is to improve lives and communities in Kansas and beyond through innovation in education, research and health care.
Specialty
Areas
-
Cancer
-
Neurology
-
Internal Medicine​
Prioritized Clinical Trial Phases
-
Phase I
-
Phase II
Trial Activation
Time
- Average turnaround time for Clinical Trial Agreements, Budget Negotiations, and IRB approval is 12 weeks.
Site Highlights
-
Extensive statewide networks to support community engagement, cancer, brain health, rare disease and pediatric research
​
-
National Cancer Institute (NCI)-designated Comprehensive Cancer Center
​
- National Institute on Aging-designated Alzheimer's Disease Research Center
​
Learn More about KUMC
​​
-
To learn more and connect with the University of Kansas Medical Center, contact Amy Moran
bottom of page